GSK plc ADR buy Citigroup Inc.
Start price
26.06.24
/
50%
€36.40
Target price
26.06.25
-
Performance (%)
-10.44%
End price
27.06.25
€32.60
Summary
This prediction ended on 27.06.25 with a price of €32.60. The prediction for GSK plc ADR disappointed with a performance of -10.44%. Dividends of €1.10 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | 7.273% | 7.273% | 45.679% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Citigroup_Inc_ for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten